Chr. Hansen Overview
- Year Founded
-
1873

- Status
-
Acquired/Merged
- Employees
-
3,834

- Latest Deal Type
-
M&A
- Financing Rounds
-
8
- Investments
-
14
Chr. Hansen General Information
Description
Producer and developer of new strains and enzymes catering to food culture, plant, animal, and human health industries. The company is engaged in food cultures and enzymes that produce and sell innovative cultures, enzymes, and probiotic products that help determine the taste, flavor, texture, shelf-life, nutritional value, and health benefits of a variety of consumer products in the food industry.
Contact Information
Website
www.chr-hansen.com(Operating Subsidiary)
Corporate Office
- Boege Allé 10-12
- 2970 Hoersholm
- Denmark
Corporate Office
- Boege Allé 10-12
- 2970 Hoersholm
- Denmark
Chr. Hansen Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Chr. Hansen Comparisons
Industry
Financing
Details
Chr. Hansen Competitors (11)
One of Chr. Hansen’s 11 competitors is Novonesis, a Corporation company based in Lyngby, Denmark.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Novonesis | Corporation | Lyngby, Denmark | ||||
DSM-Firmenich | Corporation | Kaiseraugst, Switzerland | ||||
Nucelis | Corporate Backed or Acquired | San Diego, CA | ||||
Pro Biotics | Corporation | Pasco, WA | ||||
AB-Biotics | Corporate Backed or Acquired | Saint Cugat Del Valles, Spain |
Chr. Hansen Patents
Chr. Hansen Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2023331894-A1 | Derivative bacillus strains for high abiotic stress | Pending | 30-Aug-2022 | ||
AU-2023331863-A1 | Fermentative production of oligosaccharides by microbial cells utilizing glycerol | Pending | 29-Aug-2022 | ||
AU-2023331862-A1 | Process for the production of a purified human milk oligosaccharide derived from a microbial fermentation process | Pending | 29-Aug-2022 | ||
AU-2023323868-A1 | Controlling the flavour potential and phage risk of lactococcus lactis in cheddar cheese | Pending | 12-Aug-2022 | ||
AU-2023304687-A1 | Polysaccharides resulting in improved texture of dairy products | Pending | 08-Jul-2022 | C08B37/006 |
Chr. Hansen Signals
Chr. Hansen Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Chr. Hansen Investments & Acquisitions (14)
Chr. Hansen’s most recent deal was a Merger/Acquisition with Jennewein Biotechnologie for . The deal was made on 09-Oct-2020.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Jennewein Biotechnologie | 09-Oct-2020 | Merger/Acquisition | Biotechnology | ||
UAS Laboratories | 27-Jul-2020 | Merger/Acquisition | Pharmaceuticals | ||
Astarte Probiotics | 20-Apr-2020 | Merger/Acquisition | Biotechnology | ||
BacThera | 02-Sep-2019 | Joint Venture | Biotechnology | ||
LGG | 10-Nov-2016 | Merger/Acquisition | Biotechnology |
Chr. Hansen Exits (1)
Chr. Hansen’s most recent exit was on 01-Feb-2008 from J-Pac Medical. The exit was categorized as with 2 buyers.
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
J-Pac Medical | 01-Feb-2008 | Completed |
|
Chr. Hansen FAQs
-
When was Chr. Hansen founded?
Chr. Hansen was founded in 1873.
-
Where is Chr. Hansen headquartered?
Chr. Hansen is headquartered in Hoersholm, Denmark.
-
What is the size of Chr. Hansen?
Chr. Hansen has 3,834 total employees.
-
What industry is Chr. Hansen in?
Chr. Hansen’s primary industry is Biotechnology.
-
Is Chr. Hansen a private or public company?
Chr. Hansen is a Private company.
-
What is the current valuation of Chr. Hansen?
The current valuation of Chr. Hansen is
. -
What is Chr. Hansen’s current revenue?
The current revenue for Chr. Hansen is
. -
How much funding has Chr. Hansen raised over time?
Chr. Hansen has raised $1.04B.
-
Who are Chr. Hansen’s investors?
Ardian, Novo Holdings, and PAI Partners have invested in Chr. Hansen.
-
Who are Chr. Hansen’s competitors?
Novonesis, DSM-Firmenich, Nucelis, Pro Biotics, and AB-Biotics are some of the 11 competitors of Chr. Hansen.
-
When was Chr. Hansen acquired?
Chr. Hansen was acquired on 29-Jan-2024.
-
Who acquired Chr. Hansen?
Chr. Hansen was acquired by Novonesis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »